Trials / Terminated
TerminatedNCT03196310
Single Blinded First CMC Osteoarthritis Treatment
Randomized Single Blinded First CMC Osteoarthritis Treatment: Therapy and Bracing Alone vs. Intra-Articular Corticosteroid Injection vs Intra-Articular Leukocyte Depleted Platelet Rich Plasma
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Kettering Health Network · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Platelet Concentrate | Platelet Rich plasma |
| DRUG | Corticosteroid injection | Kenalog |
| OTHER | Normal Saline | Control Group - Placebo |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
- First posted
- 2017-06-22
- Last updated
- 2026-04-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03196310. Inclusion in this directory is not an endorsement.